Ex vivo and in vitro antiplasmodial activity and toxicity of Caesalpinia decapetala (Roth) Alston (Fabaceae)
- PMID: 37549860
- DOI: 10.1016/j.jep.2023.117007
Ex vivo and in vitro antiplasmodial activity and toxicity of Caesalpinia decapetala (Roth) Alston (Fabaceae)
Abstract
Ethnopharmacological relevance: Malaria is among the most prevalent and devastating parasitic diseases globally with most cases reported in Sub-Saharan Africa. One of the major reasons for the high malaria prevalence is the ever-increasing emergence of resistant strains of malaria-causing parasites to the currently used antimalarial drugs. This, therefore, calls for the search for antimalarial compounds with alternative modes of action. Plants used in traditional medicine for the treatment of malaria offer possible sources of such compounds. Caesalpinia decapetala has been used traditionally for the treatment of various diseases including malaria. However, the antiplasmodial activity of the plant has never been reported.
Aim of the study: To determine the ex vivo and in vitro antiplasmodial activities of the extracts of the roots, stem bark and leaves of Caesalpinia decapetala.
Methodology: The roots, stem bark and leaves of Caesalpinia decapetala (Roth) Alston (Caesalpiniaceae) were collected and air-dried under a shade then extracted consecutively with dichloromethane and methanol (1:1 (v/v) (4 × 0.8 L). The extracts were tested for antiplasmodial activities against four strains of Plasmodium falciparum (W2, DD2, 3D7, and D6) and fresh P. falciparum field isolates using the SYBR green I assay. The mean fifty percent inhibition concentration (IC50) was determined for each assay. An acute oral toxicity test was done based on the Organization for Economic Cooperation and Development (OECD 425) guidelines using Swiss albino mice.
Results: The leaves and stem bark extracts showed good antiplasmodial activities with IC50 values of 4.54 and 4.86 μg/mL, respectively, when tested against the fresh field isolates ex vivo. Similarly, the roots extract showed an IC50 value of 6.49 μg/mL when tested against field isolates ex vivo. The roots extract showed the highest antiplasmodial activities among the samples when tested against W2 (IC50 = 6.12 μg/mL), DD2 (IC50 = 8.17 μg/mL), and D6 (IC50 = 16.02 μg/mL) strains of P. falciparum whereas the leaves showed the highest activity (IC50 = 9.3 μg/mL) when tested against the 3D7 strain of P. falciparum. No mortality was observed for the mice treated with 2000 mg/kg of the leaves and stem bark extracts. The mouse treated with 2000 mg/kg of the roots extracts regained weight by day 12 of the observation period.
Conclusion: Caesalpinia decapetala has the potential to suppress the growth of P. falciparum thereby contributing to combating the recurrent emergence of antimalarial drug resistance.
Keywords: Caesalpinia decapetala; Ex vivo; In vitro; Malaria; Plasmodium falciparum,.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest All authors declare no conflict of interest.
Similar articles
-
In vitro antiplasmodial activity and toxicological profile of extracts, fractions and chemical constituents of leaves and stem bark from Dacryodes edulis (Burseraceae).BMC Complement Med Ther. 2023 Jun 27;23(1):211. doi: 10.1186/s12906-023-03957-2. BMC Complement Med Ther. 2023. PMID: 37370061 Free PMC article.
-
Antimalarial and safety evaluation of extracts from Toddalia asiatica (L) Lam. (Rutaceae).J Ethnopharmacol. 2013 Jan 30;145(2):587-90. doi: 10.1016/j.jep.2012.11.034. Epub 2012 Dec 1. J Ethnopharmacol. 2013. PMID: 23207061
-
Anti-plasmodial activity of Norcaesalpin D and extracts of four medicinal plants used traditionally for treatment of malaria.BMC Complement Altern Med. 2017 Mar 24;17(1):167. doi: 10.1186/s12906-017-1673-8. BMC Complement Altern Med. 2017. PMID: 28340622 Free PMC article.
-
Antiplasmodial, antimalarial activities and toxicity of African medicinal plants: a systematic review of literature.Malar J. 2021 Aug 25;20(1):349. doi: 10.1186/s12936-021-03866-0. Malar J. 2021. PMID: 34433465 Free PMC article.
-
Brazilian plants with antimalarial activity: A review of the period from 2011 to 2022.J Ethnopharmacol. 2024 Mar 25;322:117595. doi: 10.1016/j.jep.2023.117595. Epub 2023 Dec 18. J Ethnopharmacol. 2024. PMID: 38122914 Review.
Cited by
-
Green solvent-based extraction of three Fabaceae species: A potential antioxidant, anti-diabetic, and anti-leishmanial agents.Heliyon. 2024 Jun 26;10(13):e33668. doi: 10.1016/j.heliyon.2024.e33668. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39044967 Free PMC article.
-
Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine.Pharmaceuticals (Basel). 2025 Jun 25;18(7):956. doi: 10.3390/ph18070956. Pharmaceuticals (Basel). 2025. PMID: 40732245 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials